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Objective: To observe the therapeutic effects of the point-injection with nerve growth factor (NGF) for the 
sound-perceiving nerve deafness and tinnitus. Methods: The 140 cases in this series were randomly divided 
into a treatment group of 68 cases treated by NGF injection at the points of Yifeng (TE 17) and Wangu (GB 
12), and a control group of 72 cases orally taking Xibiling (㽓↨♉) and adenosine triphosphate (ATP) and 
intramuscular injection with VB1 and VB12. Results: The total effective rate was 78.6% in the treatment 
group and 31.8% in the control group, with significant difference between the two groups (P<0.05). 
Conclusion: For treating nervous deafness and tinnitus, NGF point-injection may show good therapeutic 
effects, but inversely proportional to the illness course, age and the extent of hypoacusis. 
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The sound-perceiving nerve deafness with tinnitus is 
commonly seen in clinic. Because of the complicated 
etiology with unclear pathogenesis, there is no 
specific remedy and therapy for the treatment.  
Since 2003, the authors have adopted the nerve 
growth factor (NGF) point-injection therapy for 
treatment of the sound-perceiving nerve deafness and 
tinnitus, yielding relatively good results. A report 
follows. 
CLINICAI MATERIALS 
Criteria for admission 
The patients admitted were those who conformed to 
The Diagnostic Criteria for The Sound-perceiving 
Nerve Deafness and Tinnitus,1 with the age range 
from 18–59 years and with the illness course from 
one month to 18 years; and were those who had 
failed to respond to the previous treatments, or 
received no any treatment at all. The cochlear 
pathological changes were excluded by the ABR or 
CT exam.  
General data 
In this series, the 140 cases admitted were randomly 
divided into the following two groups. In the 
treatment group of 68 cases, 32 cases were male and 
36 were female, aged 15–59 years (45.8 on the 
average), with their illness course ranging from 1 
month to 18 years. 52 cases had tinnitus on one side, 
and 16 cases on both sides, with the mild deafness in 
21 ears, moderate in 37 ears, severe in 26 ears. In the 
control group of 72 cases, 35 cases were male and 37 
were female, aged 18–58 years (41.5 on the average), 
with their illness course ranging from 1 month to 16 
years. 59 cases had tinnitus on one side, and 13 cases 
on both sides, with the mild deafness in 24 ears, 
moderate in 36 ears, and severe in 25 ears.  
Grading of the illness condition
According to the grading criteria for tinnitus,2 grade 0 
means no tinnitus; grade ĉmeans the mildest tinnitus; 
grade Ċmeans the mild tinnitus not influencing the 
patient’s daily life and work; grade ċ means the 
moderate tinnitus with no obvious interference for the 
daily life and work; grade Č means the moderate 
tinnitus affecting the sleep and work; grade č means 
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the severe tinnitus seriously affecting the patient’s 
sleep and work, and with light vexation, anxiety and 
mental depression; and grade Ď, the tinnitus is so 
severe that the patient can not sleep and work, and 
with obvious vexation, anxiety and mental depression. 
The deafness is graded according to the criteria 
described in the medical book Otorhinolaryngology
(㘇唏ઑଢ଼⾥ᄺ ):3 26–40 dB indicate the mild 
deafness, 41–70 dB the moderate deafness, and over 
70 dB the severe deafness. 
METHODS 
The NGF point-injection therapy was used for 
patients in the treatment group. 2000 Au of NGF 
(produced by Xiamen Beidazhilu Biological 
Engineering Company) resolved with 1 ml of water 
was injected alternately into Yifeng (TE 17) and 
Wangu (GB 12) in a depth of no more than 1.5 cm, 
once every other day, for one month as a treatment 
course.  
The patients in the control group orally took Xibiling
(㽓↨♉ ) 10 mg a day at night, and adenosine 
triphosphate (ATP) 20 mg, 3 times a day; and 
intramuscular injection with 100 mg of VB1 and 500 
μg of VB12, once a day. 
Criteria for therapeutic effects 
The criteria stipulated by the Chinese Medical 
Association were adopted. Cured: the hearing 
returned to normal and/or the tinnitus disappeared 
with no relapse for over one month. Markedly 
relieved: the hearing was increased by at least 30 dB 
and/or the tinnitus was decreased by 2 grades or more. 
Improved: one of the following criteria had been 
reached: 1) the audition for single frequency was 
improved by at least 15 dB; 2) the tinnitus was 
reduced by 1 grade; 3) the progressive and/or 
fluctuating dysaudia was no longer aggravated. 
Failed: the audition for single frequency was 
improved less than 15 dB or the tinnitus was not 
improved. 
RESULTS 
Comparison of the therapeutic effects between the 
two groups (Table 1) 
The total effective rate was 78.6% in the treatment 
group and 31.8% in the control group, with a 
significant difference between the two groups 
(P<0.05). 
Relation between the illness course and the effect 
in the treatment group (Table 2) 
The total effective rate was 82.8% for the sick ears 
with illness course <1 year, and 46.2% in the sick 
ears with illness course >1 year (P<0.05). It is 
indicated that the longer the illness course is, the poor 
the effect will be. 
Relation between the age and the effect in the 
treatment group (Table 3) 
The total effective rate was 91.7% in the patients 
aged 15–29 years, 82.1% in the patients aged 30–49, 
and 40.6% in the patients aged over 50, suggesting 
that the older the age is, the poor the effect will be. 
Relation between the deaf grade and the effect in 
the treatment group (Table 4) 
The total effective rate was 85.7% in the 21 ears of 
mild deafness, 51.4% in the 37 ears of moderate 
deafness, and 46.2% in the 26 ears of severe deafness.  
The effect in patients with mild deafness was 
obviously superior to that in patients with moderate 
or severe deafness, showing a significant difference 
(P<0.05). 
Table 1. Comparison of the therapeutic effects between the two groups 
Group Sick ears Cured Markedly relieved Improved Failed Total effective rate (%)
Treatment group 84 16 24 26 18  78.6*
Control group 85 0 8 19 58 31.8 
Note: For the intergroup comparison, *P< 0.05
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Table 2. Relation between the illness course and the effect in the treatment group 
Illness course Sick ears Cured Markedly relieved Improved Failed Total effective rate (%)
< 1 year   58 15 19 14 10  82.8* 
> 1 year 26 2 5 5 14 46.2 
Note: Compared with the illness course >1 year, *P<0.05 
Table 3. Relation between the age and the effect in the treatment group 
Age group Sick ears Cured Markedly relieved Improved Failed Total effective rate (%)
15-29 24 8 9 5 2 91.7 
30-49 28 6 5 12 5 82.1 
Over 50 32 1 3 9 19 40.6 
Table 4. Relation between the deaf grade and the effect in the treatment group. 
Deaf grade Sick ears Cured Markedly relieved Improved Failed Total effective rate (%)
Mild 21 4 9 5 3 85.7* 
Moderate 37 2 5 12 18 51.4 
Severe 26 0 3 9 14 46.2 
Note: *P<0.05 as compared with moderate or severe deafness   
DISCUSSION 
TCM theory holds that the function of internal organs 
is an expression of physiological activities and 
pathological changes. Channels and collaterals are 
passages to connect the internal organs and limbs, 
circulate the qi and blood, and communicate the 
exterior with the interior. Closely related to the 
kidney, heart, liver, gallbladder and spleen, the ear is 
a place where the channels and collaterals converge.  
Wangu (GB 12), a point of the Gallbladder Channel, 
is closely related to the great auricular nerves in its 
shallow part and approaches the cochlea in its deep 
part. The point-injection given at Wangu (GB 12) can 
improve the micro-circulation, showing good effects 
for restoring the hearing and improving tinnitus.  
Under Yifeng (TE 17) are the great auricular nerve, 
auriculotemporal nerve, external carotid artery, 
external jugular vein, parotid gland, facial nerve stem, 
vagus nerve, hypoglossal nerve and glossopharyngeal 
nerve. Acupuncture at Yifeng (TE 17) can improve 
the nerve regulation, vascular nutrition and lymph 
circulation, which is helpful to deafness and tinnitus. 
NGF is a necessary factor for development, maturity, 
proliferation, division and activation of the auditory 
epithelial cells and the auditory neuronal cells, and it 
plays an important role in repairing the damaged 
neuronal cells. In the present study, the NGF 
point-injection was used to treat the sound-perceiving 
nerve deafness and timitus with a total effective rate 
of 78.6%, showing an obvious difference (P<0.05) as 
compared with the routine treatment in the control 
group. The effect is especially good in patients with 
mild deafness or short illness course, possibly 
because the auditory nerve cells have not completely 
degenerated with relatively good regenerating ability. 
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